BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 20964822)

  • 21. Selective isolation and characterization of primary cells from normal breast and tumors reveal plasticity of adipose derived stem cells.
    Weigand A; Boos AM; Tasbihi K; Beier JP; Dalton PD; Schrauder M; Horch RE; Beckmann MW; Strissel PL; Strick R
    Breast Cancer Res; 2016 Mar; 18(1):32. PubMed ID: 26968831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epcam, CD44, and CD49f distinguish sphere-forming human prostate basal cells from a subpopulation with predominant tubule initiation capability.
    Guo C; Liu H; Zhang BH; Cadaneanu RM; Mayle AM; Garraway IP
    PLoS One; 2012; 7(4):e34219. PubMed ID: 22514625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nuclear beta-catenin and CD44 upregulation characterize invasive cell populations in non-aggressive MCF-7 breast cancer cells.
    Uchino M; Kojima H; Wada K; Imada M; Onoda F; Satofuka H; Utsugi T; Murakami Y
    BMC Cancer; 2010 Aug; 10():414. PubMed ID: 20696077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crosstalk between aryl hydrocarbon receptor (AhR) and BCL-2 pathways suggests the use of AhR antagonist to maintain normal differentiation state of mammary epithelial cells during BCL-2 inhibition therapy.
    Al-Dhfyan A; Alaiya A; Al-Mohanna F; Attwa MW; AlAsmari AF; Bakheet SA; Korashy HM
    J Adv Res; 2023 Aug; 50():177-192. PubMed ID: 36307019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Generation of breast cancer stem cells through epithelial-mesenchymal transition.
    Morel AP; Lièvre M; Thomas C; Hinkal G; Ansieau S; Puisieux A
    PLoS One; 2008 Aug; 3(8):e2888. PubMed ID: 18682804
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes.
    MacDougall JR; Matrisian LM
    J Cell Sci; 2000 Feb; 113 ( Pt 3)():409-23. PubMed ID: 10639329
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncoupling of the ERα regulated morphological phenotype from the cancer stem cell phenotype in human breast cancer cell lines.
    Gadalla SE; Alexandraki A; Lindström MS; Nistér M; Ericsson C
    Biochem Biophys Res Commun; 2011 Feb; 405(4):581-7. PubMed ID: 21266162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour-initiating capacity is independent of epithelial-mesenchymal transition status in breast cancer cell lines.
    Xie G; Ji A; Yuan Q; Jin Z; Yuan Y; Ren C; Guo Z; Yao Q; Yang K; Lin X; Chen L
    Br J Cancer; 2014 May; 110(10):2514-23. PubMed ID: 24755887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell hierarchy and lineage commitment in the bovine mammary gland.
    Rauner G; Barash I
    PLoS One; 2012; 7(1):e30113. PubMed ID: 22253899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of differentiation inducers on cell phenotypes of cultured nontransformed and immortalized mammary epithelial cells: a comparative immunocytochemical analysis.
    Grünberg E; Eckert K; Karsten U; Maurer HR
    Tumour Biol; 2000; 21(4):211-23. PubMed ID: 10867614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue.
    Stingl J; Eaves CJ; Zandieh I; Emerman JT
    Breast Cancer Res Treat; 2001 May; 67(2):93-109. PubMed ID: 11519870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Breast cancer stem cells and intrinsic subtypes: controversies rage on.
    Nakshatri H; Srour EF; Badve S
    Curr Stem Cell Res Ther; 2009 Jan; 4(1):50-60. PubMed ID: 19149630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. P-cadherin is coexpressed with CD44 and CD49f and mediates stem cell properties in basal-like breast cancer.
    Vieira AF; Ricardo S; Ablett MP; Dionísio MR; Mendes N; Albergaria A; Farnie G; Gerhard R; Cameselle-Teijeiro JF; Seruca R; Schmitt F; Clarke RB; Paredes J
    Stem Cells; 2012 May; 30(5):854-64. PubMed ID: 22389315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
    Hiraga T; Ito S; Nakamura H
    Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epithelial mesenchymal transition traits in human breast cancer cell lines parallel the CD44(hi/)CD24 (lo/-) stem cell phenotype in human breast cancer.
    Blick T; Hugo H; Widodo E; Waltham M; Pinto C; Mani SA; Weinberg RA; Neve RM; Lenburg ME; Thompson EW
    J Mammary Gland Biol Neoplasia; 2010 Jun; 15(2):235-52. PubMed ID: 20521089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single Amino Acid Variant Profiles of Subpopulations in the MCF-7 Breast Cancer Cell Line.
    Tan Z; Nie S; McDermott SP; Wicha MS; Lubman DM
    J Proteome Res; 2017 Feb; 16(2):842-851. PubMed ID: 28076950
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics.
    Wei X; Dombkowski D; Meirelles K; Pieretti-Vanmarcke R; Szotek PP; Chang HL; Preffer FI; Mueller PR; Teixeira J; MacLaughlin DT; Donahoe PK
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18874-9. PubMed ID: 20952655
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IGF1R constitutive activation expands luminal progenitors and influences lineage differentiation during breast tumorigenesis.
    Farabaugh SM; Litzenburger BC; Elangovan A; Pecar G; Walheim L; Atkinson JM; Lee AV
    Dev Biol; 2020 Jul; 463(1):77-87. PubMed ID: 32376245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.